市場調查報告書
商品編碼
1468540
2024-2032 年按材料(氧化鋁、氧化鋯等)、生物相容性(生物惰性、生物活性、生物可吸收)、應用(牙科護理、骨科等)和地區分類的生物陶瓷市場報告Bioceramics Market Report by Material (Alumina, Zirconia, and Others), Biocompatibility (Bio-inert, Bio-active, Bio-resorbable), Application (Dental Care, Orthopedics, and Others), and Region 2024-2032 |
2023年全球生物陶瓷市場規模達180億IMARC Group。
生物陶瓷是指陶瓷材料的一個子類,用於修復和替換肌肉骨骼系統患病和受損的部分。用於生產生物陶瓷的一些常用材料包括生物活性玻璃、可吸收磷酸鈣、羥基磷灰石等。惰性。因此,生物陶瓷被用於骨科承重塗層、植牙、骨移植替代品和骨水泥等多種應用,例如矯正慢性脊椎彎曲、對齊和修復骨折、治療先天畸形等。
為了提高患者身體的接受度並降低術後感染的發生率,對生物相容性材料的需求不斷增加,這主要推動了全球生物陶瓷市場的發展。此外,肌肉骨骼疾病的發生率不斷上升,包括骨質疏鬆症、骨關節炎、類風濕性關節炎、背部和頸部疼痛等,尤其是老年人群,也為全球市場創造了積極的前景。除此之外,醫生在關節置換術中進行早期手術介入的新興趨勢正在推動膝關節、肩關節和髖關節植入物的使用,進而推動市場成長。此外,食物消費模式的變化以及飲食中營養的缺乏導致蛀牙形成和牙齒健康惡化的病例增加。這反過來又導致對牙冠、牙橋和刷毛的需求不斷增加,最終導致生物陶瓷在牙科護理中的滲透率不斷上升。此外,碳生物陶瓷因其輕質特性而日益普及,為患者和外科醫生在植體定位方面提供了便利,也是一個重要的生長誘導因素。除此之外,包括氧化鋯增韌氧化鋁和磷酸鈣塗層在內的新型先進材料的引入預計將滿足未來幾年全球生物陶瓷市場的成長。
The global bioceramics market size reached US$ 18.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 30.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032.
Bioceramics refers to a subclass of ceramic materials that are used to repair and replace diseased and damaged parts of the musculoskeletal system. Some of the commonly available materials utilized in the production of bioceramics include bioactive glass, resorbable calcium phosphates, hydroxyapatite, etc. Additionally, they have certain beneficial characteristics, including biocompatibility, non-toxicity, dimensional stability, and chemical inertness. As a result, bioceramics are used in orthopedic load-bearing coatings, dental implants, bone graft substitutes, and bone cement for several applications, such as correcting chronic spinal curvature, aligning and repairing fractures, treating congenital deformities, etc.
The escalating requirement for biocompatible materials to increase acceptance by the patients' bodies, as well as lower the occurrence of post-surgery infections is primarily driving the global bioceramics market. Moreover, the growing incidences of musculoskeletal conditions, including osteoporosis, osteoarthritis, rheumatoid arthritis, back and neck pain, etc., especially among the geriatric population, are also creating a positive outlook for the global market. Besides this, the emerging trend of early surgical intervention by doctors in case of joint replacements is fueling the utilization of knee, shoulder, and hip implants, which in turn, is propelling the market growth. Furthermore, the changing food consumption patterns along with the lack of nutrition in diet have resulted in the increasing cases of cavity formation and deteriorated dental health. This, in turn, has led to the elevating need for crowns, bridges, and bristles, eventually contributing to the rising penetration of bioceramics in dental care. Additionally, the escalating popularity of carbon bioceramics owing to its lightweight nature, which offers convenience to patients and surgeons in terms of implant positioning, is also acting as a significant growth-inducing factor. Apart from this, the introduction of new advanced materials, including zirconia toughened alumina and calcium phosphate coatings, is projected to cater to the growth of the global bioceramics market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bioceramics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on material, biocompatibility and application.
Alumina
Zirconia
Others
Bio-inert
Bio-active
Bio-resorbable
Dental Care
Orthopedics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being CAM Bioceramics B.V., Carborundum Universal Limited (Murugappa Group), CeramTec GmbH, CoorsTek Inc., Dentsply Sirona, Koninklijke DSM N.V., Straumann and Stryker Corporation.